CERS CERUS CORP

8-K Current Report

Filed: March 16, 2026

Health Care

Surgical & Medical Instruments & Apparatus

CERUS CORP (CERS) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Vivek Jayaraman promoted from COO to President & CEO effective July 1, 2026; 6-year internal veteran with commercial and operational background
• Outgoing CEO Obi Greenman transitions to Executive Chairman — continuity signal but also a governance overhang to watch

+3 more insights

Other CERUS CORP 8-K Filings

8-K Mar 2, 2026

Get deeper insights on CERUS CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.